Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Similar articles for PubMed (Select 23188032)

1.

Heart failure therapy: what should clinicians believe?

Fang JC.

JAMA. 2012 Nov 28;308(20):2144-6. doi: 10.1001/jama.2012.45418. No abstract available.

PMID:
23188032
2.

[Role of RAAS inhibitors for the treatment of heart failure].

Murohara T.

Nihon Rinsho. 2012 Sep;70(9):1577-81. Japanese.

PMID:
23012806
3.

Renin-angiotensin-aldosterone system inhibitors in heart failure.

Shearer F, Lang CC, Struthers AD.

Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12. Review.

PMID:
23852393
4.

Renin-Angiotensin system antagonists and mortality in patients with heart failure.

Fonarow GC, Ahmed A.

JAMA. 2013 Mar 20;309(11):1107. doi: 10.1001/jama.2013.1969. No abstract available.

PMID:
23512045
5.

Renin-Angiotensin system antagonists and mortality in patients with heart failure--reply.

Lund LH, Benson L.

JAMA. 2013 Mar 20;309(11):1107-8. doi: 10.1001/jama.2013.1975. No abstract available.

PMID:
23512046
6.

Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.

Khalid U, Deswal A.

Evid Based Med. 2013 Dec;18(6):226-7. doi: 10.1136/eb-2013-101238. Epub 2013 Apr 12. No abstract available.

PMID:
23585078
7.

Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure.

Valluri A, Struthers AD, Lang CC.

Curr Heart Fail Rep. 2014 Mar;11(1):31-9. Review.

PMID:
24234398
8.

How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?

Sexton DJ.

Circ Heart Fail. 2014 May;7(3):536. doi: 10.1161/CIRCHEARTFAILURE.113.000843. No abstract available.

9.

When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?

Bangalore S, Kumar S, Messerli FH.

Congest Heart Fail. 2013 May-Jun;19(3):107-15. doi: 10.1111/chf.12011. Epub 2012 Dec 12. Review.

PMID:
23241032
10.

The renin-angiotensin-aldosterone system and heart failure.

Sayer G, Bhat G.

Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002. Review.

PMID:
24286576
11.

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.

Lund LH, Benson L, Dahlström U, Edner M.

JAMA. 2012 Nov 28;308(20):2108-17. doi: 10.1001/jama.2012.14785.

PMID:
23188027
12.

[Renin-angiotensin system antagonists associated with reduced [corrected] mortality in diastolic heart failure].

Edner M, Lund LH.

Lakartidningen. 2013 Feb 13-19;110(7):331. Swedish. No abstract available. Erratum in: Lakartidningen. 2013 May 22-28;110(21):1000.

PMID:
23513377
13.

Crunch time for heart failure care in England and Wales.

[No authors listed]

Lancet. 2010 Dec 18;376(9758):2041. doi: 10.1016/S0140-6736(10)62280-5. No abstract available.

PMID:
21168037
14.

Effects of renin-angiotensin system blockade on mortality and hospitalization in heart failure with preserved ejection fraction.

Agarwal V, Briasoulis A, Messerli FH.

Heart Fail Rev. 2013 Jul;18(4):429-37. doi: 10.1007/s10741-012-9329-8. Review.

PMID:
22678768
15.

Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.

Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators.

Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18.

16.

[Significance of RAAS inhibition in diabetic nephropathy].

Tsuruya K, Toyonaga J.

Nihon Rinsho. 2012 Jul;70 Suppl 5:411-8. Japanese. No abstract available.

PMID:
23156430
17.

Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.

van Diepen S, Reynolds HR, Stebbins A, Lopes RD, Džavík V, Ruzyllo W, Geppert A, Widimsky P, Ohman EM, Parrillo JE, Dauerman HL, Baran DA, Hochman JS, Alexander JH.

Crit Care Med. 2014 Feb;42(2):281-8. doi: 10.1097/CCM.0b013e31829f6242.

PMID:
23982033
18.

Upstream therapy for atrial fibrillation in heart failure.

Goette A.

Heart Fail Clin. 2013 Oct;9(4):417-25, viii. doi: 10.1016/j.hfc.2013.07.010. Epub 2013 Aug 12. Review.

PMID:
24054475
19.

Modulation of the renin-angiotensin-aldosterone system in heart failure.

George J, Struthers AD, Lang CC.

Curr Atheroscler Rep. 2014 Apr;16(4):403. doi: 10.1007/s11883-014-0403-7. Review.

PMID:
24510580
20.

MY APPROACH to treating heart failure with reduced ejection fraction.

Greenberg BH.

Trends Cardiovasc Med. 2014 Nov;24(8):367-8. doi: 10.1016/j.tcm.2014.06.008. Epub 2014 Aug 19. No abstract available.

PMID:
25267506
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk